Dennis, M, Burnett, A, Hills, R, Thomas, I, Ariti, C, Severinsen, M T, Hemmaway, C, Greaves, P, Clark, R E, Copland, M, Russell, N & National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group 2021, ' A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia : results of the LI-1 trial ', British Journal of Haematology, vol. 194, no. 2, pp. 298-308 . https://doi.org/10.1111/bjh.17501 Dennis, M, Burnett, A, Hills, R, Thomas, I, Ariti, C, Severinsen, M T, Hemmaway, C, Greaves, P, Clark, R E, Copland, M, Russell, N, Kallenbach, M, Culligan, D, Duncan, C, Krishnamurthy, P, Cuthbert, A, Patalappa, C, Spanoudakis, M, Galvani, D, Berkahn, I, Patton, N, Pemberton, L, Virchis, A, Jasani, P, Parker, A, Arnold, C, Cuthbert, R, Finnega, D, Nikolousis, M, Pratt, G, Cahalin, P, Ackroyd, S, Mehta, P, Protheroe, R, Weinkove, R, Ali, S, Welch, E, Smith, M, Spearing, R, Vyas, P, Campbell, G, Hamblin, M, Wood, M, Gupta, S, Westonsmith, S, Pillai, A, Hunter, H, Kjeldsen, L, Niemann, C U, Khan, A & on behalf of the National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group 2021, ' A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia : results of the LI-1 trial ', British Journal of Haematology, vol. 194, no. 2, pp. 298-308 . https://doi.org/10.1111/bjh.17501 BRITISH JOURNAL OF HAEMATOLOGY